|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
4,739 |
$71,879.73 |
2.16% |
| The Cooper Companies, Inc. |
COO |
216648501 |
1,176 |
$71,900.64 |
2.16% |
| Cochlear Limited |
COH.AU |
Q25953102 |
714 |
$71,068.79 |
2.14% |
| Stryker Corporation |
SYK |
863667101 |
231 |
$70,716.03 |
2.13% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
980 |
$70,409.32 |
2.12% |
| Insulet Corporation |
PODD |
45784P101 |
473 |
$70,599.98 |
2.12% |
| ResMed Inc. |
RMD |
761152107 |
278 |
$70,389.60 |
2.12% |
| Alcon Inc. |
ALC.SW |
H01301128 |
1,001 |
$70,103.88 |
2.11% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
973 |
$70,036.54 |
2.11% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
857 |
$70,128.31 |
2.11% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,623 |
$70,192.21 |
2.11% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
718 |
$69,961.92 |
2.11% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,762 |
$69,880.49 |
2.10% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
592 |
$69,915.53 |
2.10% |
| Teleflex Incorporated |
TFX |
879369106 |
511 |
$69,904.80 |
2.10% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
733 |
$69,048.60 |
2.08% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,460 |
$69,017.14 |
2.08% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
175 |
$69,077.75 |
2.08% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
201 |
$68,878.20 |
2.07% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$68,686.18 |
2.07% |
| Becton, Dickinson and Company |
BDX |
075887109 |
348 |
$68,343.72 |
2.06% |
| Medtronic Plc |
MDT |
G5960L103 |
723 |
$68,533.17 |
2.06% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
41 |
$68,454.42 |
2.06% |
| Steris Plc |
STE |
G8473T100 |
298 |
$68,575.76 |
2.06% |
| Align Technology, Inc. |
ALGN |
016255101 |
448 |
$68,212.48 |
2.05% |
| BioMerieux |
BIM.FP |
F1149Y232 |
687 |
$68,230.81 |
2.05% |
| Boston Scientific Corporation |
BSX |
101137107 |
1,497 |
$68,233.26 |
2.05% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
751 |
$68,010.56 |
2.05% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
151 |
$68,196.13 |
2.05% |
| Danaher Corporation |
DHR |
235851102 |
291 |
$67,794.27 |
2.04% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
5,434 |
$67,728.77 |
2.04% |
| Abbott Laboratories |
ABT |
002824100 |
642 |
$67,332.96 |
2.03% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,251 |
$67,465.88 |
2.03% |
| LivaNova Plc |
LIVN |
G5509L101 |
837 |
$67,478.94 |
2.03% |
| Waters Corporation |
WAT |
941848103 |
147 |
$67,029.06 |
2.02% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
793 |
$66,857.83 |
2.01% |
| Baxter International Inc. |
BAX |
071813109 |
2,627 |
$66,436.83 |
2.00% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,392 |
$66,426.73 |
2.00% |
| Revvity, Inc. |
RVTY |
714046109 |
415 |
$66,561.85 |
2.00% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
97 |
$66,434.33 |
2.00% |
| Agilent Technologies, Inc. |
A |
00846U101 |
375 |
$65,985.00 |
1.99% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$65,318.51 |
1.97% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
175 |
$65,175.25 |
1.96% |
| Penumbra, Inc. |
PEN |
70975L107 |
200 |
$65,044.00 |
1.96% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
268 |
$64,947.20 |
1.95% |
| DexCom, Inc. |
DXCM |
252131107 |
760 |
$59,713.20 |
1.80% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,377 |
$57,050.06 |
1.72% |
| Olympus Corporation |
7733.JP |
J61240107 |
5,040 |
$56,049.79 |
1.69% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,543.73 |
1.34% |
| US Dollar |
$USD |
|
24,433 |
$24,433.37 |
0.74% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|